Santen, IAPB partner to implement UN resolution on eye health

Santen is partnering with the International Agency for the Prevention of Blindness to implement United Nations General Assembly Resolution A/75/L.108, focusing on eye health and sustainable development, according to a press release. The resolution “encourages governments and key stakeholders from around the world to mobilize the necessary resources to address this urgent priority,” the release said.

Adjustable IOL Maker RxSight Launches $118 Million IPO

RxSight, of Aliso Viejo, California, launched on July 30 a $118 million initial public offering of 7.35 million shares of common stock at a price of $16 per share. Shares are trading on the Nasdaq under the symbol RXST.

Study Shows Reduction in Postoperative Halos in Patients Treated With Tearscience Lipiflow Treatment Prior to Bilateral Cataract Surgery

Johnson & Johnson Vision revealed new comparative clinical study findings evaluating TearScience LipiFlow treatment in cataract surgery. The data concluded that treating patients with TearScience LipiFlow prior to cataract surgery significantly reduced patient-reports of halos compared to control group (58.6 vs. 79 percent) and showed larger improvements in Meibomian Gland Score (MGD) than control group (107 vs. 66 percent).